Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tali Mazor

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Neuro-Oncology Advances|September 9, 2020
Patient-derived cells from recurrent tumors that model the evolution of <i>IDH</i>-mutant gliomaLindsey E Jones, Stephanie Hilz, Matthew R Grimmer, et al.
The Journal of Clinical Investigation|March 21, 2017
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomasGary Kohanbash, Diego A Carrera, Shruti Shrivastav, et al.
Cancer|August 1, 2017
Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomasMichael Wahl, Susan M Chang, Joanna J Phillips, et al.
Cancer Research|November 5, 2016
Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation ProcessShigeo Ohba, Joydeep Mukherjee, Tor-Christian Johannessen, et al.
Cancers|July 13, 2024
Deconstructing Intratumoral Heterogeneity through Multiomic and Multiscale Analysis of Serial SectionsPatrick G Schupp, Samuel J Shelton, Daniel J Brody, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Deconstructing intratumoral heterogeneity through multiomic and multiscale analysis of serial sectionsPatrick G Schupp, Samuel J Shelton, Daniel J Brody, et al.
Molecular Cell|February 14, 2012
Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factorsMing Yu, Tali Mazor, Hui Huang, et al.
Pediatric Blood & Cancer|March 13, 2018
Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group studyChristopher C Dvorak, Prakash Satwani, Elliot Stieglitz, et al.
Cancer Discovery|July 12, 2022
AACR Project GENIE: 100,000 Cases and BeyondTrevor J Pugh, Jonathan L Bell, Jeff P Bruce, et al.
Neuro-Oncology|October 28, 2017
Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomasJosie Hayes, Yao Yu, Llewellyn E Jalbert, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Neuro-Oncology Advances|September 9, 2020
Patient-derived cells from recurrent tumors that model the evolution of <i>IDH</i>-mutant gliomaLindsey E Jones, Stephanie Hilz, Matthew R Grimmer, et al.
The Journal of Clinical Investigation|March 21, 2017
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomasGary Kohanbash, Diego A Carrera, Shruti Shrivastav, et al.
Cancer|August 1, 2017
Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomasMichael Wahl, Susan M Chang, Joanna J Phillips, et al.
Cancer Research|November 5, 2016
Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation ProcessShigeo Ohba, Joydeep Mukherjee, Tor-Christian Johannessen, et al.
Cancers|July 13, 2024
Deconstructing Intratumoral Heterogeneity through Multiomic and Multiscale Analysis of Serial SectionsPatrick G Schupp, Samuel J Shelton, Daniel J Brody, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Deconstructing intratumoral heterogeneity through multiomic and multiscale analysis of serial sectionsPatrick G Schupp, Samuel J Shelton, Daniel J Brody, et al.
Molecular Cell|February 14, 2012
Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factorsMing Yu, Tali Mazor, Hui Huang, et al.
Pediatric Blood & Cancer|March 13, 2018
Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group studyChristopher C Dvorak, Prakash Satwani, Elliot Stieglitz, et al.
Cancer Discovery|July 12, 2022
AACR Project GENIE: 100,000 Cases and BeyondTrevor J Pugh, Jonathan L Bell, Jeff P Bruce, et al.
Neuro-Oncology|October 28, 2017
Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomasJosie Hayes, Yao Yu, Llewellyn E Jalbert, et al.
Pageof 4